Kazmi, Muhammad Hazqeel, Dohadwala, Taha Kassim, Haleem, Syed Mohammad, Thirupathy, Umabalan, Sajnani, Piyush, Camila, Pena Campos Indira, Ayyad, Mennatalla, Ch'ng, Brandon Xian, Arshad, Muhammad Muneeb, Nasser, Ibrahim Ali, Mesmar, Ahmad, Khawaja, Muhammad Nadeem, Al-Zou'bi, Amer 'Mohammad Amin', Chatha, Salman, Tariq, Osama, Zulfiqar, Eeshal, Ahmed, Mushood and Ahmed, Raheel (2026) Comparison of P2Y inhibitors vs. aspirin monotherapy following dual antiplatelet therapy in patients after percutaneous coronary intervention: a systematic review and meta-analysis. Archives of medical sciences. Atherosclerotic diseases, 11. e24-e37. ISSN 2451-0629
Document
-
article.pdf - Published Version
Available under License Creative Commons Attribution Non-commercial Share Alike. -
Supplementary files
Comparison-of-P2Y12---Supplementary.pdf - Published Version
Available under License Creative Commons Attribution Non-commercial Share Alike.
Abstract
Abstract
IntroductionP2Y12 inhibitor monotherapy has emerged as a potential alternative to aspirin following dual antiplatelet therapy (DAPT) in patients undergoing percutaneous coronary intervention (PCI), but the optimal choice remains uncertain.MethodsA systematic literature search compared P2Y12 inhibitors with aspirin post PCI. A random-effects model pooled odds ratios (ORs) with 95% confidence intervals (CIs) for outcomes.ResultsSeven studies (29,756 patients) were included. P2Y12 inhibitors significantly reduced MACE compared to aspirin [OR = 0.73; 95% CI: 0.64-0.84]. No significant difference was observed in all-cause mortality [OR = 0.90; 95% CI: 0.77-1.05], cardiac death [OR = 0.86; 95% CI: 0.68-1.09], major bleeding [OR = 1.06; 95% CI: 0.67-1.68], MI [OR = 0.78; 95% CI: 0.56-1.08], or stent thrombosis [OR = 0.71; 95% CI: 0.41-1.22]. P2Y12 inhibitors significantly reduced repeat revascularisation [OR = 0.83; 95% CI: 0.73-0.94] and stroke [OR = 0.63; 95% CI: 0.48-0.81].ConclusionsP2Y12 inhibitors may be a safer, more effective alternative to aspirin alone after PCI.
| Item Type: | Article |
|---|---|
| Additional Information: | ** From Europe PMC via Jisc Publications Router ** History: ppub 01-01-2026; epub 30-03-2026. ** Licence for this article: cc by-nc-sa |
| Uncontrolled Keywords: | Percutaneous coronary intervention, aspirin, Clopidogrel, Ticagrelor, P2y12inhibitors |
| Related URLs: | |
| SWORD Depositor: | Publication Router |
| Depositing User: | Raheel Ahmed |
| URI: | https://sure.sunderland.ac.uk/id/eprint/20398 |
Further Details
More Information
Identifiers
Users with ORCIDS
Catalogue record
Contributors
University Divisions
Subjects
Actions (login required)
Dimensions
DimensionsDownload Statistics
Downloads per month over past year